Filters

Latest News

2021-01-25 07:00:01

Biopharmaceutical global body kicks off 2021 with new CEO leadership line up

Geneva, 25 January 2021 –The biopharmaceutical global industry, represented by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), is pleased ...

Read More

2021-01-12 11:27:48

Speak Up Africa and IFPMA start their search for winners of the Africa Young Innovators for Health Award

The Africa Young Innovators for Health Award is IFPMA and Speak Up Africa’s flagship programme ...

Read More

2020-12-08 12:45:58

Speak Up Africa and IFPMA launch the “Africa Young Innovators for Health Award” to fuel innovation and help advance promising healthcare solutions

The first edition of the “Africa Young Innovators for Health Award” aims to support entrepreneurs ...

Read More

2020-12-08 08:09:19

Pharma innovation delivers COVID-19 solutions beyond expectations, but calls for the dilution of intellectual property rights are counterproductive

8 December 2020, Geneva — The biopharmaceutical industry has made the fight against the COVID-19 ...

Read More

2020-12-07 08:40:06

A broad alliance, a crucial mission: A new multi-stakeholder association to combat falsified medicines

Seven years since its first activities as a grass-roots advocacy campaign, Fight the Fakes announces ...

Read More

2020-11-10 15:41:24

Innovative and generic & biosimilar pharmaceutical industries unite on commitment to equitable access to COVID-19 medicines and vaccines, while flagging where further help is needed from others

Geneva 10 November 2020 – On the occasion of the World Health Assembly, the world’s ...

Read More

2020-10-22 09:38:06

IFPMA launches Note for Guidance to help those acting on behalf of biopharmaceutical companies live up to its ethical business principles

GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers and Associations (IFPMA) published today ...

Read More

Latest Statement

2021-01-20 11:00:22

IFPMA, GSCF, ICBA Joint Statement on the item 14.2 Strengthening preparedness for health emergencies: implementation of the IHR @EB148

Mr Chairman, IFPMA welcomes and supports the ongoing work and interim findings of the Review Committee on the Functioning of ...

Read More

2021-01-19 08:25:31

IFPMA Statement for EB148 agenda item 14.1 Covid-19 Response

GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...

Read More

2021-01-13 08:17:19

Innovative biopharmaceutical industry comment on COVID-19 vaccines dosing strategies and recommend following the science

GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...

Read More

2020-12-07 09:15:51

IFPMA Welcomes New Fight the Fakes Alliance

GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...

Read More

2020-11-20 14:00:59

Biopharmaceutical representative joins new antibiotic resistance fighting United Nations group to avert looming superbugs public health

GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...

Read More

2020-11-18 10:00:15

Joint Statement On World Antimicrobial Awareness Week

GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...

Read More

2020-11-09 21:42:14

IFPMA/IGBA “Considerations on equitable access to COVID-19 medicines and vaccines”

GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers ...

Read More

mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig

Sadia Kaenzig - Communications Manager

Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.

mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol

Morgane De Pol - Communications and Public Affairs

Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

Hot Topic

Pharmacovigilance: Do your bit, play your part!

Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is

Read More

Interview

IFPMA 2015 interview series 'Biodiversity, human health, and pharma'

A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to

Read More

Our Blog

Latest Tweets

Collaborative partnerships are key to finding solutions to #GlobalHealth problems including #COVID19. That’s why ou… https://t.co/yfmWEU0eAQ
2 2
RT @AlbertBourla: Today @pfizer announced an agreement with #COVAX for up to 40M doses of our #COVID19 vaccine. We are a proud partner to @…
115
Now is the time to join hands and collectively build trust and confidence in #VaccinesWork and bring an end to this… https://t.co/aGlSovOUb5
13 22
“The post-pandemic world needs continued health innovation to drive #globalhealth progress in general and #SDGs in… https://t.co/K6TNxjMYa0
2 2
The biopharmaceutical industry remains deeply committed to #beatNTDs. Ahead of this year's World #NTD Day, read our… https://t.co/WCEIYpgVTp
1 2